Muromachi ChemicalsMUROMACHI CHEMICALS INC.4885東証スタンダード医薬品FY ending May 2026, non-consolidated, J-GAAP
Revenue by business segment, and the profit each one keeps.
Geographic revenue reported in annual filings
No geographic revenue breakdown was disclosed.
※ Segment figures include inter-segment sales and do not sum to the company total
X-axis: segment revenue CAGR. Y-axis: latest operating margin. Bubble size: revenue.
Bubble size represents latest revenue. Segments without a CAGR are placed at the left edge; their horizontal position is not a growth value. Color indicates positive or negative margin.
| Segment | Revenue CAGR | FY ending May 2022 | FY ending May 2023 | FY ending May 2024 | FY ending May 2025 | FY ending May 2026 |
|---|---|---|---|---|---|---|
| Pharmaceutical business | +9.9%5y | 2,91315.5% | 3,52515.3% | 3,25914.6% | 3,21814.7% | 3,98615.9% |
| Healthy food business | +8.2%5y | 8240.2% | 658-18.3% | 834-4.5% | 1,043-9.4% | 1,1861.5% |
| Chemical products business | +10.0%5y | 1,944-0.8% | 2,108-2.3% | 2,276-0.7% | 2,3922.4% | 2,6693.4% |
Top: revenue. Bottom: operating margin.
EDINET (FSA Japan)
有価証券報告書-第80期(2025/06/01-2026/05/31)
EDINET (FSA Japan)
有価証券報告書-第79期(2024/06/01-2025/05/31)
EDINET (FSA Japan)
有価証券報告書-第78期(2023/06/01-2024/05/31)
EDINET (FSA Japan)
有価証券報告書-第77期(2022/06/01-2023/05/31)
EDINET (FSA Japan)
有価証券報告書-第76期(令和3年6月1日-令和4年5月31日)
EDINET (FSA Japan)
有価証券報告書-第75期(令和2年6月1日-令和3年5月31日)
Extracted from XBRL: 48 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.